| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |